FOI_7482

Internal Reference Number: FOI_7482

Date Request Received: 11/10/2023 00:00:00

Date Request Replied To: 20/10/2023 00:00:00

This response was sent via: By Email

Request Summary: Melanoma & RCC

Request Category: Researcher


Question Number 1: How many patients have been treated in the past 3 months with the following agents for renal cell carcinoma (any stage): • Avelumab + Axitinib • Axinitib • Cabozantinib • Everolimus • Lenvantinib + Everolimus • Nivolumab monotherapy • Nivolumab + Cabozantinib • Nivolumab + Ipilimumab • Pazopanib • Pembrolizumab monotherapy • Pembrolizumab + Axitinib • Pembrolizumab + Lenvatinib • Radiotherapy only • Sunitinib • Temsirolimus • Tivozanib • Other active systemic anti-cancer therapy • Palliative care only

Answer To Question 1: We don’t treat these tumour types at Salisbury NHS Foundation Trust, patients go to University Hospital Southampton.

Question Number 2: How many patients have been treated in the past 3 months with the following agents for melanoma (any stage) : • Cobimetinib • Dabrafenib • Dabrafenib AND Trametinib • Dacarbazine • Denosumab • Encorafenib AND Binimetinib • Ipilimumab • Ipilimumab AND Nivolumab • Nivolumab • Pembrolizumab • Trametinib • Vemurafenib • Vemurafenib AND Cobimetinib • Other active systemic anti-cancer therapy • Palliative care only

Answer To Question 2: We don’t treat these tumour types at Salisbury NHS Foundation Trust, patients go to University Hospital Southampton.

Question Number 3: Does you trust participate in any clinical trials for the treatment of renal cell carcinoma? If so please provide the name of each trial and number of patients that are taking part?

Answer To Question 3: Salisbury NHS Foundation Trust is not currently participating in any clinical trials for the treatment of renal cell carcinoma.

To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.